Rapid drug-susceptibility testing of Mycobacterium tuberculosis.

Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (1981) 9.67

Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method. Antimicrob Agents Chemother (1988) 2.87

Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods. J Clin Microbiol (1985) 2.68

Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis. Antimicrob Agents Chemother (1986) 2.48

Evolution and clonal traits of Mycobacterium tuberculosis complex in Guinea-Bissau. J Clin Microbiol (1999) 2.23

Conventional and radiometric drug susceptibility testing of Mycobacterium tuberculosis complex. J Clin Microbiol (1983) 2.08

Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methods. Antimicrob Agents Chemother (1985) 2.07

Recovery and susceptibility testing of Mycobacterium tuberculosis from extrapulmonary specimens by the BACTEC radiometric method. J Clin Microbiol (1984) 1.93

Mutations in the rpoB gene of Mycobacterium tuberculosis that interfere with PCR-single-strand conformation polymorphism analysis for rifampin susceptibility testing. J Clin Microbiol (1997) 1.89

Evaluation of the BACTEC radiometric method for detection of 1% resistant populations of Mycobacterium tuberculosis. J Clin Microbiol (1985) 1.85

Rapid susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP. Antimicrob Agents Chemother (1988) 1.76

Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol. Antimicrob Agents Chemother (2005) 1.75

Radiometric method for testing susceptibility of mycobacteria to pyrazinamide in 7H12 broth. J Clin Microbiol (1985) 1.71

Determination of in vitro susceptibility of Mycobacterium tuberculosis to cephalosporins by radiometric and conventional methods. Antimicrob Agents Chemother (1985) 1.55

Biochemical heterogeneity of Mycobacterium tuberculosis complex isolates in Guinea-Bissau. J Clin Microbiol (1993) 1.47

MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs. Antimicrob Agents Chemother (1988) 1.42

Evaluation of streptomycin and ethambutol concentrations for susceptibility testing of Mycobacterium tuberculosis by radiometric and conventional procedures. J Clin Microbiol (1986) 1.38

Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry. J Clin Microbiol (1995) 1.17

Development of a rapid method for determining the susceptibility of Mycobacterium tuberculosis to isoniazid using the Gen-Probe DNA Hybridization System. Antimicrob Agents Chemother (1989) 1.13

The impact of HIV on the usefulness of sputum smears for the diagnosis of tuberculosis. Am J Public Health (1991) 1.07

Susceptibility testing of filamentous fungi to amphotericin B by a rapid radiometric method. J Clin Microbiol (1984) 1.02

Rapid method for testing susceptibility of Mycobacterium tuberculosis by using DNA probes. J Clin Microbiol (1997) 0.94

New drug susceptibility test for Mycobacterium tuberculosis using the hybridization protection assay. J Clin Microbiol (1996) 0.92

Rapid susceptibility testing for nontuberculosis mycobacteria using flow cytometry. J Clin Microbiol (1996) 0.83

An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med (1992) 18.11

Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA (1995) 15.26

The emergence of drug-resistant tuberculosis in New York City. N Engl J Med (1993) 12.71

The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol (1993) 11.70

Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media. Am Rev Respir Dis (1977) 11.20

INFECTION OF MICE WITH MAMMALIAN TUBERCLE BACILLI GROWN IN TWEEN-ALBUMIN LIQUID MEDIUM. J Exp Med (1947) 10.82

Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (1981) 9.67

Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med (1991) 8.98

Identification of mycobacteria by high-performance liquid chromatography. J Clin Microbiol (1991) 7.27

Identification of major slowly growing pathogenic mycobacteria and Mycobacterium gordonae by high-performance liquid chromatography of their mycolic acids. J Clin Microbiol (1988) 6.42

Variation in the susceptibility of strains of Staphylococcus aureus to oxacillin, cephalothin, and gentamicin. Antimicrob Agents Chemother (1976) 6.26

Nationwide survey of drug-resistant tuberculosis in the United States. JAMA (1994) 6.14

Current practices in mycobacteriology: results of a survey of state public health laboratories. J Clin Microbiol (1993) 5.99

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. Am J Respir Crit Care Med (1994) 5.66

Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis (1983) 5.66

Tuberculosis in the United States. JAMA (1989) 5.12

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob Agents Chemother (1996) 5.08

Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA (1994) 4.44

The new tuberculosis. N Engl J Med (1992) 4.37

Emergence of Buruli ulcer disease in the Daloa region of Cote d'Ivoire. Am J Trop Med Hyg (1995) 4.32

Identification of clinically significant Mycobacterium fortuitum complex isolates. J Clin Microbiol (1981) 4.24

Multidrug-resistant tuberculosis. Ann Intern Med (1992) 4.06

Mycobacterium avium-intracellulare: a cause of disseminated life-threatening infection in homosexuals and drug abusers. Ann Intern Med (1982) 3.58

The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis (1987) 3.48

Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis (1982) 3.38

Separation of Mycobacterium bovis BCG from Mycobacterium tuberculosis and Mycobacterium bovis by using high-performance liquid chromatography of mycolic acids. J Clin Microbiol (1992) 3.36

Decreasing reliability of acid-fast smear techniques for detection of tuberculosis. Ann Intern Med (1975) 3.31

High-performance liquid chromatography patterns of mycolic acids as criteria for identification of Mycobacterium chelonae, Mycobacterium fortuitum, and Mycobacterium smegmatis. J Clin Microbiol (1990) 3.27

Rapid radiometric methods to detect and differentiate Mycobacterium tuberculosis/M. bovis from other mycobacterial species. Am Rev Respir Dis (1984) 3.25

Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida. Ann Intern Med (1984) 3.25

Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis (1993) 3.16

Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis (1978) 3.15

Identification of Mycobacterium avium complex strains and some similar species by high-performance liquid chromatography. J Clin Microbiol (1992) 3.03

Mycobacterium celatum sp. nov. Int J Syst Bacteriol (1993) 2.97

Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis (1990) 2.81

Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob Agents Chemother (1989) 2.68

Opportunistic pathogens in the genus Mycobacterium. Annu Rev Microbiol (1985) 2.67

Isolation and characterization of a unique group of slowly growing mycobacteria: description of Mycobacterium lentiflavum sp. nov. J Clin Microbiol (1996) 2.66

Tuberculosis morbidity in the United States: final data, 1990. MMWR CDC Surveill Summ (1991) 2.53

High-performance liquid chromatography of mycolic acids as a tool in the identification of Corynebacterium, Nocardia, Rhodococcus, and Mycobacterium species. J Clin Microbiol (1986) 2.51

Multidrug-resistant tuberculosis in the New York State prison system, 1990-1991. J Infect Dis (1994) 2.45

Improved method for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Clin Microbiol (1982) 2.44

Clindamycin-induced enterocolitis in hamsters. J Infect Dis (1978) 2.43

Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism. J Clin Microbiol (1993) 2.40

Geographic distribution, frequency, and specimen source of Mycobacterium avium complex serotypes isolated from patients with acquired immunodeficiency syndrome. J Clin Microbiol (1990) 2.35

Risk factors for transmission of Mycobacterium tuberculosis in a primary school outbreak: lack of racial difference in susceptibility to infection. Am J Epidemiol (1994) 2.34

Fourth report of the cooperative, open-ended study of slowly growing mycobacteria by the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1991) 2.31

Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity. Antimicrob Agents Chemother (1983) 2.25

Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis. Antimicrob Agents Chemother (1979) 2.24

Epidemiology of tuberculosis in the United States. Epidemiol Rev (1989) 2.23

Mycobacterial taxonomy. Eur J Clin Microbiol Infect Dis (1994) 2.23

Peritonitis due to a mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. J Infect Dis (1982) 2.20

Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin. Am Rev Respir Dis (1973) 2.18

Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy. JAMA (1986) 2.18

Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am Rev Respir Dis (1979) 2.15

Bacterial studies of Clindamycin-associated colitis. A preliminary report. Gastroenterology (1975) 2.13

The booster phenomenon in serial tuberculin testing. Am Rev Respir Dis (1979) 2.13

THE EFFECT OF TUBERCLE BACILLI ON THE POLYMORPHONUCLEAR LEUCOCYTES OF NORMAL ANIMALS. J Exp Med (1950) 2.12

Tuberculosis in the 1980s. N Engl J Med (1980) 2.09

Changing practices in mycobacteriology: a follow-up survey of state and territorial public health laboratories. J Clin Microbiol (1996) 2.06

Semantide- and chemotaxonomy-based analyses of some problematic phenotypic clusters of slowly growing mycobacteria, a cooperative study of the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1996) 2.02

Analysis of mycolic acid cleavage products and cellular fatty acids of Mycobacterium species by capillary gas chromatography. J Clin Microbiol (1986) 1.97

High-performance liquid chromatography analysis of mycolic acids as an aid in laboratory identification of Rhodococcus and Nocardia species. J Clin Microbiol (1987) 1.95

In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin. Am Rev Respir Dis (1982) 1.92

Allopurinol in the treatment of American cutaneous leishmaniasis. N Engl J Med (1992) 1.89

Differential identification of mycobacteria. I. Tests on catalase activity. Am Rev Respir Dis (1966) 1.89

The relationship between tuberculosis and silicosis. Am Rev Respir Dis (1978) 1.89

Detection of pneumococci in respiratory secretions: clinical evaluation of gentamicin blood agar. J Clin Microbiol (1977) 1.83

Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients. J Clin Microbiol (1992) 1.82

Rapid identification of mycolic acid patterns of mycobacteria by high-performance liquid chromatography using pattern recognition software and a Mycobacterium library. J Clin Microbiol (1994) 1.80

Bacteriophage types of Mycobacterium tuberculosis in the United States. Am Rev Respir Dis (1982) 1.76

The tuberculin skin test. Am Rev Respir Dis (1982) 1.75

Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann Intern Med (1983) 1.75

Effect of ethambutol on the viable cell count in Mycobacterium smegmatis. Antimicrob Agents Chemother (1977) 1.72

Chronic tenosynovitis of the hand due to Mycobacterium nonchromogenicum: use of high-performance liquid chromatography for identification of isolates. Rev Infect Dis (1992) 1.70

Successful intermittent treatment of smear-positive pulmonary tuberculosis in six months: a cooperative study in Poland. Am Rev Respir Dis (1982) 1.69

The prevalence of tuberculosis and drug resistance among Haitians. N Engl J Med (1982) 1.68

Current tuberculosis screening practices. Am J Public Health (1984) 1.67

ELISA tests for antibodies against mycobacterial glycolipids. J Immunol Methods (1980) 1.67

Prevalence of nontuberculous mycobacteria in water supplies of hemodialysis centers. Appl Environ Microbiol (1988) 1.67

Purine metabolism in Leishmania donovani and Leishmania braziliensis. Biochim Biophys Acta (1978) 1.60

The usefulness of phage typing Mycobacterium tuberculosis isolates. Am Rev Respir Dis (1984) 1.58

Acquired immunodeficiency syndrome and extrapulmonary tuberculosis in the United States. Arch Intern Med (1990) 1.57

Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli. Am Rev Respir Dis (1985) 1.56

Extrapulmonary tuberculosis in Oklahoma, 1965 to 1973. Am Rev Respir Dis (1975) 1.54

Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity. J Med Chem (1996) 1.54

Ultraviolet susceptibility of BCG and virulent tubercle bacilli. Am Rev Respir Dis (1976) 1.53

The epidemiology of tuberculosis in the United States. Semin Respir Infect (1989) 1.52

Diagnostic mycobacteriology laboratory practices. Clin Infect Dis (1995) 1.52

Allopurinol ribonucleoside as an antileishmanial agent. Biological effects, metabolism, and enzymatic phosphorylation. J Biol Chem (1979) 1.49

Serovar determination and molecular taxonomic correlation in Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum: a cooperative study of the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1993) 1.48

Effects of ethambutol on phospholipid metabolism in Mycobacterium smegmatis. Antimicrob Agents Chemother (1981) 1.47

A tissue culture system for the growth of several species of Leishmania: growth kinetics and drug sensitivities. Am J Trop Med Hyg (1988) 1.47

Treatment of tuberculosis during pregnancy. Am Rev Respir Dis (1980) 1.46